GlassScriptPhysician profile
Kristin Babb
NPI 1598843831
$16,245.87
in general payments reported to CMS, 2019-2025
23 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $765 · 2023: $58.66 · 2024: $420 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14,283.88 | 2021-2022 | |
| Boston Scientific Corporation | $473.58 | 2021-2024 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $170.01 | 2021-2025 | |
| Cvrx, INC. | $145.38 | 2021 | |
| Edwards Lifesciences Corporation | $134.74 | 2022 | |
| Medtronic, INC. | $130.64 | 2021 | |
| Abbott Laboratories | $123.44 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $121.77 | 2024 | |
| Philips North America LLC | $112.01 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $100.91 | 2024-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.84 | 2022 | |
| Janssen Pharmaceuticals, INC | $71.13 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $56.12 | 2021 | |
| Merck Sharp & Dohme LLC | $53.53 | 2023-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $35.32 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $28.66 | 2024 | Urgoclean Ag |
| Biosense Webster, INC. | $28.02 | 2023 | Carto 3 |
| Kerecis Limited | $21.43 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Astrazeneca Pharmaceuticals LP | $19.34 | 2024 | Wainua |
| Altathera Pharmaceuticals LLC | $16.69 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Lantheus Medical Imaging, INC. | $14.13 | 2022 | |
| Elutia, INC. | $11.30 | 2024 | Ecm Patch,Pouch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Babb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.